Marker Therapeutics (MRKR)
4.40
-0.03 (0.68%)
Upcoming Events
Latest Headlines
Form 8-K Marker Therapeutics, For: Apr 08
April 8, 2024 7:09 AM - SEC Filing
Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
April 8, 2024 7:00 AM - Globe NewsWire
Form 8-K Marker Therapeutics, For: Mar 25
March 26, 2024 6:02 AM - SEC Filing
Form 10-K Marker Therapeutics, For: Dec 31
March 26, 2024 6:02 AM - SEC Filing
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
March 25, 2024 5:45 PM - StreetInsider
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 22, 2024 12:30 PM - Globe NewsWire
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors
March 12, 2024 8:01 AM - BizWire
Form 8-K Marker Therapeutics, For: Feb 29
March 1, 2024 8:03 AM - SEC Filing
Form 8-K Marker Therapeutics, For: Feb 22
February 26, 2024 7:59 AM - SEC Filing
Full Article List
